Commentary on “Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: A retrospective analysis with independent validation.” Kapur P, Peña-Llopis S, Christie A, Zhrebker L, Pavía-Jiménez A, Rathmell WK, Xie XJ, Brugarolas J. Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX.: Lancet Oncol 2013; 14(2):159–67. [Epub 2013 Jan 16]. doi: 10.1016/S1470-2045(12)70584-3.

Autor: Boorjian, Stephen
Zdroj: In Urologic Oncology: Seminars and Original Investigations August 2014 32(6):934-935
Databáze: ScienceDirect
Externí odkaz: